Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday that the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
"I would love this to be clarified. We come to a deal on trade, boy, this market is up 10 to 15%, but without it's going to be worrisome," Jeremy Siegel says.Marketsread more
The final week of August could be highly volatile as markets fret over the economy and the latest developments in trade wars.Market Insiderread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
Bank of England Governor Mark Carney says trade war has a confidence effect on business around the worldMarketsread more
CVS Health now anticipates its $69 billion acquisition of health insurer Aetna to close after Thanksgiving, the company said Tuesday in a regulatory filing. Executives earlier this month said they expected the deal to close before the holiday.
The company has received approval from 26 of the 28 state departments of insurance it needs to close the deal, CVS said in the filing with the Securities and Exchange Commission. The filing said CVS has made "significant progress" in the approval process and is in "the final stages" with the remaining two states.
On a Nov. 6 call with Wall Street analysts to discuss third-quarter earnings results, CEO Larry Merlo said state approvals of the deal were on track to allow the companies to close before Thanksgiving.
Shares of CVS dipped about 3 percent Tuesday.
The companies announced the deal last December. The Department of Justice granted preliminary approval in October. CVS said Aetna would sell its Medicare Part D drug plan business to WellCare Health Plans for an undisclosed amount to ease concerns about the overlap between CVS' and Aetna's Medicare Part D plans.
Tuesday was outgoing Chief Financial Officer David Denton's first day at home improvement retailer Lowe's. He was slated to make the move after the CVS-Aetna deal closed. Eva Boratto has replaced Denton at CVS.